VITRO DIAGNOSTICS INC
SC 13D, 1999-09-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MORGAN KEEGAN SOUTHERN CAPITAL FUND INC, 24F-2NT, 1999-09-28
Next: CISTRON BIOTECHNOLOGY INC, 10-K, 1999-09-28





                                  United States
                       Securities and Exchange Commission
                             Washington, D.C. 20549

                          Commission File No.: 00017378

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934


                             VITRO DIAGNOSTICS, INC.
                              --------------------
                                (Name of Issuer)


                                     Common
                                     ------
                         (Title of Class of Securities)


                                   928501-30-3
                                  -----------
                                 (Cusip Number)


Lloyd Hansen, 2646 SW Mapp Road, Suite 304, Palm City, FL 34990
- ---------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)

                                December 29, 1998
                                -----------------
             (Date of Event which Requires Filing of this Statement)


         If the filing person has  previously  filed a statement on Schedule 13G
to report the  acquisition  which is the subject of this  Schedule  13D,  and is
filing this schedule because of Rule 13- d(b)(3) or (4), check the following box
/ /.

         Check the following box if a fee is being paid with the statement  /X/.
(A fee  is not  required  only  if the  reporting  person:  (1)  has a  previous
statement on file  reporting  beneficial  ownership of more than five percent of
the class of  securities  described  in Item 1; and 92) has  filed no  amendment
subsequent  thereto  reporting  beneficial  ownership of five percent or less of
such class.) (See Rule 13d-7)



<PAGE>



                                  SCHEDULE 13D

CUSIP NO.: 928501-30-3


1.       Name of Reporting Person and
         S.S. or I.R.S. Identification No.

         Lloyd Hansen
         2646 SW Mapp Road, Suite 304,
         Palm City, FL 34990
         ###-##-####

2.       Check the Appropriate Box if A Member of a Group*

                  a /X/
                  b /  /

3.       SEC Use Only


4.       Source of Funds

         OO

5.       Check Box if Disclosure of Legal Proceedings is Required
         Pursuant to Items 2(d) or 2(e)

         /  /

6.       Citizenship or Place of Organization

                  State of TN, USA

7.       Sole Voting Power

         1,280,000

8.       Shared Voting Power

         0

9.       Sole Dispositive Power

         1,280,000

10.      Shared Dispositive Power

         0

11.      Aggregate Amount Beneficially Owned by Each Reporting Person




<PAGE>



12.      Check Box if the Aggregate Amount in Row (11) Excludes Certain
         Shares

         /  /

13.      Percent of Class Represented by Amount in Row (11)

         19.9% @ December 31, 1998

14.      Type of Reporting Person

         IN

Item 1.           Security & Issuer

         This  statement  relates to common shares of Vitro  Diagnostics,  Inc.,
8100 Southpark Way, Bldg. B-1, Littleton, CO 80120

Item 2.

         a.       Lloyd Hansen

         b.       2646 SW Mapp Road, Suite 304, Palm City, FL 34990

         c.       Mr. Hansen is a business man whose principal  occupation is as
                  President of Nortek, Inc.

         d.       The  reporting  person nor any of its managers have during the
                  last  five  years  been  convicted  in a  criminal  proceeding
                  (excluding traffic violations).

         e.       The  reporting  person has not during the last five years been
                  subject to or party to a civil  proceeding of any type nor has
                  any judgment, decree or order of any type been entered against
                  reporting person.

         f.       Citizenship: USA

Item 3.           Source and Amount of the Funds

         Personal funds of Reporting Party.

Item 4.           Purpose of the Transaction

         The  transaction was to purchase the  controlling  shareholders  (Lloyd
Fields)  interest in Vitro  Diagnostics,  Inc. which  constituted  56.85% of the
outstanding  common  stock of Vitro  Diagnostics,  Inc.  with World Wide Capital
Investors,  LLC (3,650,000  shares).  Reporting Party,  Lloyd Hansen,  purchased
1,280,000  shares  or  19.9%  of the  outstanding  stock.  There  is no  pooling
arrangement  for voting  purposes and no  cross-options  or purchase  agreements
between World Wide Capital Investors, LLC. and Lloyd Hansen.



<PAGE>



Item 5.           Interest in Securities of the Issuer

         a.       1,280,000 common shares (19.9%) of issuer as of December
                  31, 1998 are owned beneficially and of record by
                  Reporting Party.

         b.       Reporting  party has sole  power to vote  1,280,000  shares of
                  common stock.

         c.       None.

         d.       Not Applicable

         e.       Not Applicable

Item 6.           Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer.

         The  information  contained  in  response  to  Items  4 and 5,  and the
Exhibits A, B, C, and D attached hereto are incorporated herein.

         The  Reporting  Person had an  understanding  with  World Wide  Capital
Company,  a purchaser of 1,280,000  shares  (19.9%) of the common stock of Vitro
Diagnostics,  Inc.,  whereby  they  cooperated  in the  purchase of the total of
3,650,000  shares of the Vitro  Diagnostics,  Inc.  from  Lloyd  Fields and each
contributed  cash to the purchase of the shares and divided the shares purchased
pro rata.  Mr.  Hansen's  shares may be included in any  Registration  Statement
filed by World Wide Capital Investors, LLC.

Item 7.           Exhibits

         i)       Subscription Agreement
         ii)      Subscription Agreement


<PAGE>



                                    SIGNATURE


         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.





Dated: September 28, 1999               ----------------------------------------
                                        Lloyd Hansen






                    STOCK PURCHASE AND SUBSCRIPTION AGREEMENT



This Stock  Purchase  and  Subscription  agreement  (herein  referred  to as the
"Agreement") is made this 24th day of December,  1998, by and between World Wide
Capital Company  (herein  referred to as the "Company") and Lloyd Hansen (herein
referred to as the "Purchaser").

WHEREAS, the Company has arranged for shares of Vitro Diagnostics,  Inc. (herein
referred to as the "stock"),  a Nevada  Corporation traded on the bulletin board
under Vitro Diagnostics, Inc. (VODG).

WHEREAS, the Company is making the following representations:

         A.       That the stock has been arranged for with good and
                  reasonable consideration.
         B.       That the  restrictive  legends will be removed under a pending
                  agreement with Vitro Diagnostics, Inc. in which a registration
                  statement will be filed.
         C.       That the stock is unencumbered.

WHEREAS,  the Purchaser is desirous of purchasing  through the Company shares of
Vitro Diagnostics, Inc. for $0.40 per share.

WHEREAS, the Purchaser is making the following representations:

         A.       That under the definitions of the Securities Act of
                  1933 the Purchaser is accredited.
         B.       That all  questions of the Company  have been  answered to the
                  satisfaction of the Purchaser.

NOW  THEREFORE,  it is agreed that the  Purchaser is  subscribing  for 1,000,000
Shares  of  Vitro  Diagnostics,  Inc.  at  $0.40  per  share,  and  has  already
transferred $ 400,000 to Pueblo Bank & Trust to settle the transaction.

EXECUTED BY PURCHASER:

- ---------------------------               ----------------------------------
Purchaser (Signature)                     Purchaser's Social Security Number

  Lloyd G. Hansen                         EXECUTED BY
                                          WORLD WIDE CAPITAL CO.:


2646 SW Mapp Rd, Ste. 304                 /s/ Brett G. Brubaker
                                          ----------------------------------
Purchaser Address                         Brett G. Brubaker, Partner
                                          World Wide Capital Company
Palm City, FL 34990                       Prentice Point Tower - 5th Floor
                                          Greenwood Village, CO 80111






                    STOCK PURCHASE AND SUBSCRIPTION AGREEMENT



This Stock  Purchase  and  Subscription  agreement  (herein  referred  to as the
"Agreement") is made this 24th day of December,  1998, by and between World Wide
Capital  Company  (herein  referred  to as the  "Company")  and Lloyd G.  Hansen
(herein referred to as the "Purchaser").

WHEREAS, the Company has arranged for shares of Vitro Diagnostics,  Inc. (herein
referred to as the "stock"),  a Nevada  Corporation traded on the bulletin board
under Vitro Diagnostics, Inc. (VODG).

WHEREAS, the Company is making the following representations:

         A.       That the stock has been arranged for with good and
                  reasonable consideration.
         B.       That the  restrictive  legends will be removed under a pending
                  agreement with Vitro Diagnostics, Inc. in which a registration
                  statement will be filed.
         C.       That the stock is unencumbered.

WHEREAS,  the Purchaser is desirous of purchasing  through the Company shares of
Vitro Diagnostics, Inc. for $0.40 per share.

WHEREAS, the Purchaser is making the following representations:

         A.       That under the definitions of the Securities Act of
                  1933 the Purchaser is accredited.
         B.       That all  questions of the Company  have been  answered to the
                  satisfaction of the Purchaser.

NOW THEREFORE, it is agreed that the Purchaser is subscribing for 280,000 Shares
of Vitro  Diagnostics,  Inc. at $0.40 per share,  and has already  transferred $
112,000 to Pueblo Bank & Trust to settle the transaction.

EXECUTED BY PURCHASER:

- ---------------------------              ----------------------------------
Purchaser (Signature)                    Purchaser's Social Security Number

  Lloyd G. Hansen                        EXECUTED BY
                                         WORLD WIDE CAPITAL CO.:


2646 SW Mapp Rd, Ste. 304                /s/ Brett G. Brubaker
                                         ----------------------------------
Purchaser Address                        Brett G. Brubaker, Partner
                                         World Wide Capital Company
Palm City, FL 34990                      Prentice Point Tower - 5th Floor
                                         Greenwood Village, CO 80111




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission